Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT02351232
Clinical Trials · NCT02351232
The Lira Pump Trial
Completed
Phase 2/Phase 3
Liraglutide
(Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
Hvidovre University Hospital
Enrollment
44
Start date
Feb 2015
Locations
2 sites, Denmark
Primary endpoint
Change in HbA1c
View Liraglutide compound reference